CD274 and neoplasm: Importantly, the immunological differences between pediatric and adult patients explain why pediatric tumors are less responsive than adult tumors to immunotherapeutic tumor treatments, particularly treatments that utilize immune checkpoint inhibitors (ICI) such as anti-PD-1/PD-L1 [97].